Vraylar 1.5 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FXVW1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,696
Award facts
- Contract value 100% obligated
- $12,696.23 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,696.23 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30 capsules of Vraylar 1.5 mg, a medication used to treat psychiatric conditions. The order, issued on January 28, 2026, with completion expected by January 29, 2026, represents a routine pharmaceutical procurement executed through the company's existing contract vehicle with DLA. This delivery order is not set aside for any specific business classification and was competitively awarded based on AmerisourceBergen's established capability to fulfill federal medical supply requirements. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania.
This order falls under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2031. The IDC serves as a comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen leverages this prime contract relationship to efficiently fulfill task orders for military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26FXVW1?
SPE2DR26FXVW1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FXVW1 worth?
The government has obligated $12,696 on SPE2DR26FXVW1.
Is contract SPE2DR26FXVW1 an order under another contract?
Yes. SPE2DR26FXVW1 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXVW1 competed?
The extent of competition for SPE2DR26FXVW1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award